ICON plc (ADR) (NASDAQ:ICLR)
CAPS Rating:
The Company is a contract research organization, providing clinical research and development services on a global basis to the pharmaceutical, biotechnology and medical device industries.
RSS Headlines
Fool UK
Recs
As big pharma trys to reduce costs of geting products to market they will rely more heavily on outsourcing clinical trials.